Quick Answer
In Texas, peptide therapy is a prescription written by a Texas-licensed physician and dispensed by a licensed 503A compounding pharmacy for one named patient. It is not a supplement, it is not available over the counter, and it is not something a patient can lawfully buy from a research-chemical website for personal use. The peptides are prescribed off-label, which is legal and common, and is not the same thing as being approved.
This article is about mechanics: how a legitimate peptide prescription is written, dispensed and sourced in this state, and how a patient can tell a lawful supply chain from an unlawful one. It is not about federal regulatory status — the Category 1 and Category 2 lists and the February 2026 announcement are covered in peptide therapy FDA status 2026, and there is no point restating it here.
What 503A Actually Means
Compounding is the preparation of a medication that is not commercially available in the form a patient needs. American law splits it in two.
Section 503A of the Federal Food, Drug, and Cosmetic Act covers traditional pharmacy compounding: a licensed pharmacy prepares a medication for an identified individual patient, against a valid prescription from a licensed prescriber. That is the route peptide therapy runs through. Section 503B covers outsourcing facilities, which compound in batches without patient-specific prescriptions, register with the FDA and are inspected against a different standard. Both are lawful; they do different jobs. The FDA maintains the current compounding laws and policies publicly.
Why this matters to you as a patient: a 503A preparation exists because someone wrote your name on a prescription. If a clinic cannot tell you which licensed pharmacy compounds its peptides, the medicine is not coming through this route.
The Texas Layer
Two Texas regulators sit on top of the federal framework, and both keep a public register you can search for free.
The Texas Medical Board licenses physicians and publishes a verification tool at profile.tmb.state.tx.us. Dr. Jaqua holds Texas Medical Board licence P6362, which you can check there in about a minute — the reason it is published on this site rather than described in the abstract. Her credentials and how she practises are on her about page, and the peptide-specific version is at the peptide specialist section of the peptide therapy page.
The Texas State Board of Pharmacy licenses the pharmacies, including out-of-state pharmacies shipping into Texas, and its register is at pharmacy.texas.gov. A legitimate peptide program is verifiable from both directions: the prescriber and the pharmacy.
Off-Label Prescribing, Explained Properly
This is the single most misunderstood point in the whole topic, and it gets misrepresented in both directions.
When the FDA approves a drug, it approves it for specific indications, with labelling to match. A licensed physician may then prescribe that drug for a different indication, a different population or a different route if their clinical judgement supports it. That is off-label prescribing. It is legal, it is regulated through the practice of medicine rather than through the label, and it is ordinary: large parts of paediatrics, oncology and psychiatry run on it.
What off-label does notmean is that the FDA has reviewed and endorsed the use. It has not. A clinic that says “it is legal, so it is approved” is wrong, and so is a critic who says “it is not approved, so it is illegal”. The accurate statement for compounded peptides is the flat one: they are prescribed off-label at physician discretion, they are compounded by a licensed 503A pharmacy, and they have not received drug approval from the FDA for the uses described.
Category 1, Category 2, and Why Some Peptides Are Not Available
The FDA maintains lists governing which bulk drug substances a 503A pharmacy may compound with. Substances in Category 1 may be used while under evaluation; substances placed in Category 2 have been flagged with significant safety risks and may not. That is a supply-side restriction on the pharmacy, not a statement about any individual patient.
The practical consequence is that a peptide can be perfectly well documented in the literature and still be unavailable lawfully. BPC-157 is the clearest example: it sits on the Category 2 list, which is why licensed 503A pharmacies cannot compound it, and Vitality Texas does not currently offer BPC-157 pending the formal FDA publication that would restore its compounding status. TB-500 is in the same position, and is discussed educationally rather than dispensed. The current state of that process is tracked in the FDA status article.
A clinic advertising a Category 2 peptide as available now is telling you something about its supply chain that you should take seriously.
Sourcing Safety: What to Ask, and What to Walk Away From
Ask any clinic these five questions:
- Is there a physician consultation before anything is prescribed?
- Are labs drawn, and are they reviewed by the prescriber?
- Which licensed compounding pharmacy dispenses the medication?
- Is the preparation patient-specific, written in my name?
- What follow-up is included, and who do I contact if something changes?
The counter-signals are just as clear:
- No prescription and no consultation
- No labs, or labs that nobody discusses with you
- “Research use only — not for human consumption” labelling
- Overseas shipping direct to a consumer
- An unnamed or unverifiable pharmacy
The risk here is not theoretical. Independent testing reported by the FDA, state agencies and others has consistently found that compounded drugs fail to meet specification — including potency — at a considerably higher rate than commercially manufactured, approved products, and compounded sterile preparations carry an additional risk of microbial contamination.1 Between January 2000 and the 2012 fungal meningitis outbreak, eleven separate outbreaks of healthcare-associated infection in the United States were traced to contaminated compounded drugs, involving 207 infected patients and 17 deaths.2 The 2012 outbreak itself, caused by contaminated methylprednisolone acetate from a single compounding pharmacy, reached 749 reported cases across 20 states with 61 deaths.3 All of that happened inside the licensed, inspected system. A vial bought from an unregulated vendor has none of those safeguards and no record when something goes wrong.
Cost is a fair question to ask alongside all of this, and what drives it is set out in how much does peptide therapy cost.
What This Looks Like at Vitality
Consultation, labs, a prescription written by the physician who read them, dispensing by a licensed 503A compounding pharmacy, and follow-up with the same physician. Every peptide prescribed here is used off-label and none has received drug approval from the FDA for the uses described. Where a peptide cannot lawfully be compounded, it is not prescribed and the reason is stated rather than worked around.
Frequently Asked Questions
Is peptide therapy legal in Texas?
Prescribed peptide therapy is legal in Texas when a physician licensed by the Texas Medical Board writes a patient-specific prescription and a pharmacy licensed by the Texas State Board of Pharmacy compounds and dispenses it. What is not legal is buying peptides for personal use from a research-chemical vendor. Legality attaches to the prescription and the pharmacy, not to the molecule.
Do I need a prescription?
Yes. These are prescription drugs, not supplements. A legitimate program involves an evaluation, labs where clinically appropriate, and a prescription written for you by name. Anything that skips those steps is skipping the part that makes it lawful.
What is a 503A compounding pharmacy?
Section 503A of the Federal Food, Drug, and Cosmetic Act covers traditional pharmacy compounding — preparing a medication for an identified individual patient against a valid prescription. That is different from a 503B outsourcing facility, which produces batches without patient-specific prescriptions and registers with and is inspected by the FDA. Peptide therapy for an individual patient runs through the 503A route.
Is peptide therapy approved by the FDA?
No. Compounded peptide preparations have not been through FDA drug review, and no peptide protocol at this clinic is being described as approved. They are prescribed off-label, which means a licensed physician is exercising clinical judgement to prescribe for a use outside an approved label. Off-label prescribing is legal and routine across American medicine — it is a different thing from approval, and it is the distinction most peptide marketing blurs.
Can I just buy peptides online instead?
You can find vendors selling them, usually labelled 'for research use only, not for human consumption'. That labelling is what allows the sale, and it also tells you the product was never made to be injected into a person. There is no prescription, no named pharmacy, no sterility or potency assurance and no physician following what happens next. The published record of contamination and potency failures in compounded sterile injectables is the reason the licensed route exists.
How do I check that my physician and pharmacy are licensed?
Both registers are public and free. Physician licences are searchable at profile.tmb.state.tx.us, and pharmacy licences at the Texas State Board of Pharmacy. Any clinic that will not name its compounding pharmacy has given you your answer.
References
- Gudeman J, Jozwiakowski M, Chollet J, Randell M. “Potential Risks of Pharmacy Compounding.” Drugs R D. 2013;13(1):1–8. DOI: 10.1007/s40268-013-0005-9
- Staes C, Jacobs J, Mayer J, Allen J. “Description of outbreaks of health-care-associated infections related to compounding pharmacies, 2000–12.” Am J Health Syst Pharm. 2013;70(15):1301–1312. DOI: 10.2146/ajhp130049
- Smith RM, Schaefer MK, Kainer MA, et al. “Fungal Infections Associated with Contaminated Methylprednisolone Injections.” N Engl J Med. 2013;369(17):1598–1609. DOI: 10.1056/NEJMoa1213978
This article is general information about how prescribing and compounding work in Texas. It is not legal advice and it is not medical advice. Peptide protocols are prescribed off-label at physician discretion following individual evaluation and have not received drug approval from the FDA for the uses described.